Cited 0 times in
A phase 1/2a, dose-escalation, safety, and preliminary efficacy study of the RKP00156 vaginal tablet in healthy women and patients with cervical intraepithelial neoplasia 2
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.